Researchers examined whether flash therapy, given during sleep, changed the sleep architecture to shift the human circadian clock.
Gilead, Merck’s experimental long-acting HIV treatment heads to Phase 3
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS